P2.04-75 Overall Survival by IDO1 and PD-L1 Expression in NSCLC Patients Receiving an Immune Checkpoint Inhibitor (ICI)

Autor:	R. Hall, J. Melson, Erin M. McLoughlin, B. Horton, Ryan D. Gentzler, M. Moore, A. Mills
Rok vydání:	2019
Předmět:	Pulmonary and Respiratory Medicine Oncology business.industry Immune checkpoint inhibitors Cancer research Overall survival Medicine Pd l1 expression business
Zdroj:	Journal of Thoracic Oncology. 14:S738
ISSN:	1556-0864
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::4e10f222213b25bd32b4f267561acf6d https://doi.org/10.1016/j.jtho.2019.08.1580 Zobrazit plný text záznamu